Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
25 participants
OBSERVATIONAL
2013-01-31
2018-12-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Internet-Based Weight-Loss Program for Colorectal Cancer Survivors
NCT01032590
Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers
NCT00410579
Incidence of Colorectal Cancer in Southwest China: Based on SCC Database
NCT06172049
Effects of Yoga on Cognitive and Immune Function in Colorectal Cancer
NCT02564835
Effect of Exercise on Biomarkers of Colon Cancer Risk
NCT00668161
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Specific Aims
1. Examine the relationships among quality of life, demands of illness, sexual functioning, and peripheral neuropathy, for the total sample and by chemotherapy group.
2. Examine changes within-subjects (four measurement occasions), between-group (chemotherapy, no-chemotherapy) differences, and the interaction between time and chemotherapy group for quality of life, demands of illness, sexual functioning, and peripheral neuropathy across four measurement occasions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chemotherapy Group
Colon cancer survivors who undergo open or laparoscopic resection of their colon cancers followed by adjuvant chemotherapy.
No interventions assigned to this group
No Chemotherapy Group
Colon cancer survivors who undergo open or laparoscopic resection of their colon cancer and who do not receive chemotherapy.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Biopsy Proven Colon Cancer
* Plan to undergo open, laparoscopic or robotic surgical colectomy.
Exclusion Criteria
* Surgical resection below the rectal sigmoid junction
* Does not speak or read English
* Scheduled to receive radiation therapy during the data collection period
* Diagnosis of metastatic colon cancer (Stage IV)
* A previous history of cancer diagnosed with the past five years with the exception of early basal cell or squamous skin cancer or early stage melanoma
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Cancer Society, Inc.
OTHER
Washington State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeanne M Robison, PhD, ARNP
Role: PRINCIPAL_INVESTIGATOR
Washington State University, College of Nursing
Mel Haberman, PhD, FAAN
Role: PRINCIPAL_INVESTIGATOR
Washington State University, College of Nursing
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Deaconess Hospital
Spokane, Washington, United States
Sacred Heart Medical Center
Spokane, Washington, United States
Holy Family Hospital
Spokane, Washington, United States
Valley Hospital
Spokane, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DSCN-11-194-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.